Probiotic Supplement as Treatment for Students With ADHD
A Double-Blind Placebo Controlled Study of Probiotic Supplement as Treatment for Students With Attention Deficit Hyperactivity Disorder (ADHD)
1 other identifier
interventional
45
0 countries
N/A
Brief Summary
Subjects will answer the following questionnaire and tests:
- Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)
- Demographic Questionnaire - composed by the researchers
- Family Eating Habits Questionnaire (FEAHQ-33)
- Food Frequency Questionnaire (FFQ)
- Test MOXO The subjects will take the study product for six months. After six months the subject will fill once again all the questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2016
CompletedFirst Posted
Study publicly available on registry
September 21, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedSeptember 12, 2018
September 1, 2018
2.8 years
September 18, 2016
September 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Reduce symptoms of attention deficit measured by MOXO test
After six month of treatment reduce symptoms of attention deficit will be measured by MOXO test
Six month
Study Arms (2)
Probiotic
ACTIVE COMPARATORProbiotic capsules: two capsules twice a day
Placebo
PLACEBO COMPARATORProbiotic capsules without the active ingredient: two capsules twice a day
Interventions
Eligibility Criteria
You may qualify if:
- Students registered in the college's Support Center for Students with Learning Disabilities and who have been diagnosed by a computerized didactic assessment -MATAL - as well as an attention diagnosis by a psychiatrist or a neurologist,
- Students who are not treated by medication or alternative treatment,
- Students who are not due to complete their education at Tel Hai College during the study period,
- Students who have signed on an informed consent form,
- No dairy intolerance (student can consume milk without any adverse effects),
- No soy allergy,
- Not currently taking any antibiotics or probiotics,
- Not pregnant or planning to become pregnant during the study period,
- Not been diagnosed with any of the following:
- Cancer
- HIV/AIDS
- Crohn's disease
- Ulcerative colitis
- Immune compromised illness
- Other serious illness
You may not qualify if:
- Students treated by any type of treatment for Attention Deficit Hyperactivity Disorder,
- Students who have not been assessed by MATAL and a psychiatrist,
- Students who take antibiotics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tel Hai Collegelead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Snait Tamir, Professor
snait@telhai.ac.il
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2016
First Posted
September 21, 2016
Study Start
November 1, 2016
Primary Completion
September 1, 2019
Study Completion
October 1, 2019
Last Updated
September 12, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share